Zoekresultaten - 11 results
Delayed treatment in breast cancer patients during the COVID-19 pandemic: a population health information research infrastructure (PHIRI) case study
Publication Type: Peer reviewed scientific article Authors: Estupiñán-Romero, Francisco; Royo-Sierra, Santiago; González-Galindo, Javier; Martínez-Lizaga, Natalia; Bogaert, Petronille; Nienke Schutte; Van Eycken, Liesbet; Van Damme, Nancy; Henau, Kris; Ly ...
Papilloplex HR-HPV test has non-inferior clinical performance for detection of human papillomavirus infection: assessment using the VALGENT framework.
cytologically abnormal specimens (100 atypical squamous cells of unspecified significance, 100 low-grade squamous intraepithelial lesions, 97 high-grade squamous intraepithelial lesions). Cases were defined as ...
PRECISION: the Belgian molecular profiling program of metastatic cancer for clinical decision and treatment assignment.
provide access to a targeted drug for patients whose tumors harbor actionable mutations in case the matched drug is not available through reimbursement or clinical trials in Belgium. Health Topics: Kanker ...
Tackling cervical cancer in Europe amidst the COVID-19 pandemic.
estimates for 2018, approximately 33 000 cases of cervical cancer occurred and 15 000 people died from the disease in Europe (see map in appendix). Human papillomavirus (HPV) vaccine coverage is relatively ...
Impact of the human papillomavirus status on the development of high-grade cervical intraepithelial neoplasia in women negative for intraepithelial lesions or malignancy at the baseline: A 9-year Swedish nested case-control follow-up study.
Volume 125, Issue 2 (2019) Keywords: Adult Case-Control Studies Female Follow-Up Studies Human papillomavirus 16 Human papillomavirus 18 Humans middle aged Papillomaviridae Papillomavirus Infections Risk ...
Clinical and Analytical Evaluation of the Anyplex II HPV HR Detection Assay within the VALGENT-3 Framework.
specificity of 1.00 (95% CI, 0.99 to 1.01) (value of >0.05 in all cases). Regardless of the clinical outcome (CIN2 + or CIN3 +), age restriction (women ≥30 years old), or comparator test used, Anyplex ...
The use of the permanent sample (eps) to study the returnto- work after cancer. Challenges and opportunities for research
Approximately 40 % of new cancer cases are diagnosed every year in the working age population (20-64 years). Maintaining their quality of life results, among others, in their retain on the labour market. Even ...
Are 20 human papillomavirus types causing cervical cancer?
phylogenetically related types (HPV26, HPV53, HPV66, HPV67, HPV68, HPV70 and HPV73) were identified as single HPV infections in certain rare cases of cervical cancer and were considered possibly carcinogenic (2B ...
Clinical evaluation of a GP5+/6+-based luminex assay having full high-risk human papillomavirus genotyping capability and an internal control.
Genotyping Tests) project. This panel consisted of cervical specimens from approximately 1,000 women attending routine screening, “enriched” with 300 women with abnormal cytology. Cases were defined as women ...
HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis
including a meta-regression to explore sources of heterogeneity. FINDINGS 148 studies were included, contributing data for 12 163 cases of head and neck squamous cell carcinoma from 44 countries. HPV DNA was ...